A worldwide leader in injectable drug administration will be the newest company to set up shop in Greenfield, and anticipates ...

Enter generative AI, which the pharma industry is adopting at a terrific rate. By ingesting and analysing vast biological ...

While the Trump administration remains unpredictable, some pharma experts are optimistic that the regulatory landscape will ...

The Singapore-based AI clinical trial engine powering Asia’s—especially China’s—rapid rise in the biotech industry. Deep ...

Ahead of JPM, Big Pharma has a moment; Lilly nears deal for Ventyx Biosciences; Vaccine schedule overhaul tees up fresh ...

Pharmaceutical companies are getting a fresh look for a range of drugs in development, plus a regulatory reprieve.

From the corporate jets of Teterboro Airport to the crowded halls of the J.P. Morgan Healthcare Conference, it’s a good time ...

The plant will focus on serving health care companies by developing and commercializing medical devices, drug delivery ...

Many pharma buyers have seen their stocks rise on deal news, a sign investors want them to keep transacting. And some ...

With Johnson & Johnson’s participation, 15 of 17 companies contacted by the administration over the summer have now signed on ...

Oregon’s attorney general filed a lawsuit Wednesday against three insulin manufacturers and the nation’s largest pharmacy ...